NCT07246863 2026-03-04Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLCCatalYm GmbHPhase 2 Recruiting131 enrolled
NCT07237425 2025-12-04Intralesional Ronkyla Plus Injection for the Treatment of Superficial LipomaGlonova Pharma Co., LtdPhase 1 Recruiting56 enrolled
NCT05951777 2025-09-29Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain InjuryHope Biosciences Research FoundationPhase 2 Recruiting51 enrolled
NCT05394714 2025-09-23A Phase I, Autologous ex Vivo Expanded and Activated NK Cell, Magicell-NK, Infusion for Colon Cancer Post Resection StudyMedigen Biotechnology CorporationPhase 1 Recruiting18 enrolled
NCT05440227 2025-06-05PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer PatientsPhytoHealth CorporationPhase 2 Recruiting36 enrolled